RT @RichardPAConway: Song et al. Korean study shows better persistence of tocilizumab than TNFi as first-line biologic i
Tweet Content
Song et al. Korean study shows better persistence of tocilizumab than TNFi as first-line biologic in RA. No difference in incidence of TB. @RheumNow #ACR22 Abstr#0887 https://t.co/EuQkfDZd77 https://t.co/VxJmKEzAVY
Links
Comparison of Drug Persistence and Incidence of Tuberculosis Between Tumor Necr…
https://acrabstracts.org/abstract/comparison-of-drug-persistence-and-incidence-…
Show on Archive Page
On
Display in Search Results
On
PDQ
Off